Haemonetics (HAE) Other Non-Current Liabilities (2010 - 2026)

Haemonetics has reported Other Non-Current Liabilities for 17 years, with the latest figure at $59.4 million in Q1 2026.

• For the quarter ending Q1 2026, Other Non-Current Liabilities fell 12.91% year-over-year to $59.4 million; the trailing twelve-month figure through Mar 2026 stood at $59.4 million (down 12.91% YoY), and the FY2026 full-year result was $59.4 million, down 12.91% from the prior year.
• Other Non-Current Liabilities for Q1 2026 stood at $59.4 million, down from $63.6 million in the prior quarter.
• The five-year high for Other Non-Current Liabilities was $92.3 million in Q2 2024, with the low at $59.4 million in Q1 2026.
• Average Other Non-Current Liabilities over 5 years is $75.7 million, with a median of $74.9 million recorded in 2023.
• Year-over-year, Other Non-Current Liabilities climbed 28.71% in 2024 and slipped 29.3% in 2025.
• Tracing HAE's Other Non-Current Liabilities over 5 years: stood at $78.2 million in 2022, then retreated by 2.51% to $76.3 million in 2023, then gained by 17.97% to $90.0 million in 2024, then fell by 29.3% to $63.6 million in 2025, then dropped by 6.62% to $59.4 million in 2026.
• The last three Other Non-Current Liabilities figures came in at $59.4 million (Q1 2026), $63.6 million (Q4 2025), and $66.1 million (Q3 2025), per Business Quant data.

Peer Comparison